Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 5,178 | 7,317 | 4,986 | 5,026 | 4,252 |
| Operating Income | -5,178 | -7,317 | -4,986 | -5,026 | -4,252 |
| Other Income | 370 | 314 | 161 | 17 | -21 |
| Pre-tax Income | -4,808 | -7,003 | -4,825 | -5,009 | -4,273 |
| Income Tax | -330 | -558 | -335 | -532 | N/A |
| Net Income Continuous | -4,478 | -6,445 | -4,490 | -4,477 | -4,273 |
| Net Income | $-4,478 | $-6,445 | $-4,490 | $-4,477 | $-4,273 |
| EPS Basic Total Ops | -7.50 | -10.50 | -7.50 | -7.00 | -7.75 |
| EPS Basic Continuous Ops | -7.40 | -10.23 | -7.08 | -7.06 | -7.73 |
| EPS Diluted Total Ops | -7.50 | -10.50 | -7.50 | -7.00 | -7.75 |
| EPS Diluted Continuous Ops | -7.40 | -10.23 | -7.08 | -7.06 | -7.73 |
| EBITDA(a) | $-5,146 | $-7,292 | $-4,962 | $-5,008 | $-4,234 |